Human antibodies against IL13 and therapeutic uses

Details for Australian Patent Application No. 2006303452 (hide)

Owner Novartis AG

Inventors Campbell, Emma Michelle; Valkirs, Gunars; Buechler, Joe; Parveen, Sofia

Agent Davies Collison Cave

Pub. Number AU-B-2006303452

PCT Pub. Number WO2007/045477

Priority 0616666.4 22.08.06 GB; 0521509.0 21.10.05 GB

Filing date 19 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 9 June 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/045477 Priority application(s): WO2007/045477

9 June 2011 Application Accepted

  Published as AU-B-2006303452

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006303453-Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders

2006303444-Hexosylceramides as adjuvants and their uses in pharmaceutical compositions